Broomfield, CO – September 14, 2004 – Unigen Pharmaceuticals, Inc., a leading research and development facility and supplier of proprietary, biologically active plant-derived ingredients to the natural products and pharmaceutical industries, has announced the appointment of Dr. Qi Jia to the position of Chief Scientific Officer effective September 1. He was formerly Unigen’s Vice President of Scientific Affairs.
In addition to his previous responsibilities overseeing the Natural Products Laboratory, Dr. Jia is now in charge of directing and managing the Discovery and Screening Laboratory and the Quality Control department. His primary responsibilities include coordinating and directing all scientific research at Unigen, improving research & development efficiency and maximizing product discovery potential.
Since joining Unigen in 1995, Dr. Jia has established collaborations with six worldwide organizations to collect indigenous medicinal plants, and has been a key player in the development of a proprietary natural product ethnomedicinal plant library containing thousands of collections, part of the company’s PhytoLogix™ technology platform. Dr. Jia has been instrumental in developing the company’s drug discovery technology platform, especially in the area of high-throughput fractionation and purification, online data collection, structure dereplication, lead discovery, chemo-informatics and product development.
“Qi has been a driving force behind the success of Unigen and its scientific advancements and is highly respected by his industry peers,” commented Regan Miles, Unigen’s Executive Vice President. “As we keep expanding our product pipeline and scientific capabilities, we will continue to rely upon Qi for his valuable scientific guidance and medicinal plant expertise.”
Jia said, “I look forward to working closely with Regan and the rest of the Unigen team to increase the penetration of Unigen’s products and PhytoLogix™ technology platforms into the cosmetic, skincare, pharmaceutical and nutraceutical industries, and to strengthen our presence in the scientific community. Another of my primary goals is to increase Unigen’s patent portfolio and to protect our intellectual property.”
Dr. Jia holds a Bachelor’s degree in Medicinal Chemistry from Beijing University and a Ph.D. in Organic Chemistry from Texas Christian University. He is an expert in the field of ethnomedicinal plants, which he has studied for twenty years. His research projects at Beijing University focused on the use of Traditional Chinese Medicine, particularly regarding its anti-tumor, anti-inflammatory and immune stimulation activities. Dr. Jia’s postgraduate work at Texas Christian University involved the discovery of drug leads from Bolivian medicinal plants for the treatment of HIV infection, cancer, tuberculosis and fungal infections.
Dr. Jia holds 15 issued and pending patents, has co-authored 26 presentations at international science conferences, and has co-authored papers appearing in 24 peer-reviewed publications in the field of natural product chemistry.
# # #
About Unigen Pharmaceuticals, Inc.
Unigen is a leading natural products research and development company and proprietary ingredients supplier. The company is dedicated to the discovery of botanically derived therapeutic compounds that address consumer health needs and help improve the quality of human life. Its research and discovery process includes extensive work at both the human cell and gene level. Unigen (www.unigenpharma.com), and sister company Aloecorp, are subsidiaries of Univera, Inc. Unigen and Aloecorp each focus on identifying and studying the unique ingredients of medicinal botanicals (Aloecorp’s focus is on Aloe vera) and then formulating proprietary raw materials for use in cosmeceutical, nutraceutical and pharmaceutical products.
Unigen Pharmaceuticals, Inc.
Regan Miles, Executive Vice President
Email Address: Re[email protected]
Telephone: 303-438-8666 Ext. 11